Sooma Medical key facts
as of Oct 2026- Developer of non-invasive brain stimulation devices designed to treat neurological and psychiatric disorders.
- Sooma Medical is valued at approximately $17.6M as of Oct 2026 (last reported valuation).
- It has raised $8.5M; the latest was Later Stage VC in Oct 2025.
- Notable investors include European Innovation Council, Innovestor, Business Finland, Lifeline Ventures, Verge Capital Management — 16 tracked in total.
- Status: Privately Held (backing).
Sooma Medical's last reported valuation, Mar 2024. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch Sooma Medical: the Monday email on marks, rounds and moves
Sooma Medical funding rounds
No funding rounds for Sooma Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Sooma Medical
16+Sooma Medical valuation
Sooma Medical's last reported valuation was $17.6 million in Mar 2024. No priced round, secondary trade or fund mark has surfaced since.
Sooma Medical investors
16 investors are on record for Sooma Medical, including European Innovation Council, Innovestor, Business Finland and Lifeline Ventures.
About Sooma Medical
Developer of non-invasive brain stimulation devices designed to treat neurological and psychiatric disorders. The company offers neurological therapy devices for non-invasive treatment options for selected disorders affecting the central nervous system, along with other effective medical devices, enabling physicians to change psychiatric and neurological care with accessible therapies at home.
- Sector
- Healthcare
- HQ
- Helsinki, Finland
- Founded
- 2013
- Employees
- 22
- Website
- soomamedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.